Workflow
Shareholder litigation
icon
Search documents
Shareholder Alert: The Ademi Firm investigates whether Two Harbors Investment Corp. is obtaining a Fair Price for its Public Shareholders
Prnewswire· 2025-12-18 15:00
Group 1 - The Ademi Firm is investigating TWO (NYSE: TWO) for possible breaches of fiduciary duty and other legal violations related to its transaction with UWM Holdings Corporation [1] - In the transaction, TWO shareholders will receive 2.3328 shares of UWMC Class A Common Stock for each share of TWO common stock, equating to a value of $11.94 per share based on UWMC's closing price as of December 16, 2025 [2] - Upon completion of the transaction, UWM shareholders will own approximately 87% of the combined company, while TWO shareholders will own approximately 13% [2] Group 2 - The transaction agreement imposes significant penalties for TWO if it accepts competing bids, which raises concerns about the conduct of the TWO board of directors and their fiduciary duties to all shareholders [3] - The investigation focuses on whether the board is acting in the best interests of all shareholders, particularly in light of substantial benefits for TWO insiders as part of the change of control arrangements [2][3]
LRN INVESTOR ALERT: Stride, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit
Prnewswire· 2025-12-18 03:07
Core Viewpoint - The Stride, Inc. class action lawsuit alleges significant misconduct by the company and its executives, including fraudulent practices that inflated enrollment numbers and ignored compliance requirements, leading to substantial financial losses for investors [3][4][5]. Group 1: Allegations of Misconduct - The lawsuit claims that Stride inflated enrollment figures by retaining "ghost students" and cut staffing costs by overloading teachers beyond statutory limits [3]. - It is alleged that Stride ignored compliance requirements, including background checks and special education services, and suppressed whistleblowers who reported financial directives to delay hiring and deny services [3]. - A complaint filed by the Gallup-McKinley County Schools Board of Education against Stride included allegations of fraud and deceptive practices, which reportedly led to a nearly 12% drop in Stride's stock price [4]. Group 2: Financial Impact - Following a report of poor customer experience, Stride announced that it faced "higher withdrawal rates" and "lower conversion rates," estimating a loss of approximately 10,000-15,000 enrollments, which contributed to a more than 54% decline in stock price [5]. - The lawsuit indicates that these issues have resulted in a muted outlook for Stride compared to previous years [5]. Group 3: Legal Process - Investors who purchased Stride securities during the specified class period can seek appointment as lead plaintiff in the class action lawsuit, which allows them to represent the interests of all class members [6]. - The lead plaintiff can choose a law firm to litigate the case, and participation as lead plaintiff does not affect an investor's ability to share in any potential recovery [6]. Group 4: About the Law Firm - Robbins Geller Rudman & Dowd LLP is a leading law firm specializing in securities fraud and shareholder litigation, having secured over $2.5 billion for investors in 2024 alone [7]. - The firm has been recognized for its significant recoveries in securities class action cases, including the largest recovery in history of $7.2 billion in the Enron case [7].
Shareholder Alert: The Ademi Firm investigates whether Inspirato Incorporated is obtaining a Fair Price for its Public Shareholders
Prnewswire· 2025-12-17 17:38
Core Viewpoint - The Ademi Firm is investigating Inspirato for potential breaches of fiduciary duty and other legal violations related to its transaction with Exclusive Investments [1][2]. Group 1: Transaction Details - Inspirato shareholders are set to receive $4.27 per share in an all-cash transaction [2]. - The transaction includes substantial benefits for Inspirato insiders as part of change of control arrangements [2]. Group 2: Board Conduct - The transaction agreement imposes significant penalties on Inspirato if it accepts competing bids, which may limit competing transactions unreasonably [2]. - The investigation focuses on whether the Inspirato board of directors is fulfilling their fiduciary duties to all shareholders [2].
Kuehn Law Encourages Investors of Firefly Aerospace Inc. to Contact Law Firm
TMX Newsfile· 2025-12-17 15:52
Core Viewpoint - Kuehn Law, PLLC is investigating potential breaches of fiduciary duties by certain officers and directors of Firefly Aerospace Inc. related to misrepresentation of the company's performance and prospects [1]. Group 1: Allegations of Misrepresentation - A federal securities lawsuit claims that insiders at Firefly Aerospace misrepresented or failed to disclose critical information, including overstated demand and growth prospects for its Spacecraft Solutions offerings [2]. - The lawsuit also alleges that Firefly overstated the operational readiness and commercial viability of its Alpha rocket program [2]. - The revelations from the lawsuit are expected to have a material negative impact on the company, indicating that public statements made by Firefly were materially false and misleading [2]. Group 2: Shareholder Actions - Shareholders who purchased FLY shares prior to September 1, 2025, are encouraged to contact Kuehn Law, as there may be limited time to enforce their rights [3]. - Kuehn Law covers all case costs and does not charge its investor clients, emphasizing the importance of shareholder participation in maintaining market integrity [4].
Kuehn Law Encourages Investors of Stride, Inc. to Contact Law Firm
TMX Newsfile· 2025-12-17 15:49
New York, New York--(Newsfile Corp. - December 17, 2025) - Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Stride, Inc. (NYSE: LRN) breached their fiduciary duties to shareholders. According to a federal securities lawsuit, Insiders at Stride caused the company to misrepresent or fail to disclose that Stride was: (1) inflating enrollment numbers by retaining "ghost students"; (2) cutting staffing costs by assigning teachers' caseloads far beyon ...
Shareholder Alert: The Ademi Firm investigates whether Udemy Inc. is obtaining a Fair Price for its Public Shareholders
Prnewswire· 2025-12-17 15:42
Core Viewpoint - The Ademi Firm is investigating Udemy for potential breaches of fiduciary duty and other legal violations related to its transaction with Coursera, which is valued at approximately $2.5 billion [1][2]. Group 1: Transaction Details - Udemy shareholders will receive $0.800 shares of Coursera common stock for each Udemy share in an all-stock transaction [2]. - The transaction is valued at approximately $2.5 billion based on closing prices from December 16, 2025 [2]. Group 2: Board Conduct and Shareholder Rights - The transaction agreement imposes significant penalties on Udemy for accepting competing bids, which may limit competing transactions [3]. - The investigation focuses on whether the Udemy board of directors is fulfilling their fiduciary duties to all shareholders [3].
Kuehn Law Encourages Investors of Primo Brands Corporation to Contact Law Firm
TMX Newsfile· 2025-12-17 15:36
New York, New York--(Newsfile Corp. - December 17, 2025) - Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Primo Brands Corporation (NYSE: PRMB) breached their fiduciary duties to shareholders. According to a federal securities lawsuit, Insiders at Primo Brands caused the company to misrepresent or fail to disclose that: the merger integration between Primo Water and BlueTriton Brands was tracking poorly due to, among other things, technology a ...
Kuehn Law Encourages Investors of Freeport-McMoran Inc. to Contact Law Firm
TMX Newsfile· 2025-12-17 15:11
Core Viewpoint - Kuehn Law, PLLC is investigating potential breaches of fiduciary duties by certain officers and directors of Freeport-McMoran Inc. (NYSE: FCX) towards shareholders [1] Group 1: Allegations of Misconduct - A federal securities lawsuit claims that insiders at Freeport-McMoran misrepresented or failed to disclose critical safety issues at the Grasberg Block Cave mine in Indonesia [2] - The lawsuit states that Freeport did not adequately ensure safety at the mine, which heightened the risk of worker fatalities [2] - This lack of safety measures led to undisclosed risks related to regulatory, litigation, and reputational concerns, making previous statements about Freeport's business and operations materially false and misleading [2]
Shareholder Alert: The Ademi Firm investigates whether United Security Bancshares is obtaining a Fair Price for its Public Shareholders
Prnewswire· 2025-12-17 14:53
Core Viewpoint - The Ademi Firm is investigating United Security Bancshares for potential breaches of fiduciary duty related to its transaction with Community West Bancshares [1] Transaction Details - United Security Bancshares shareholders will receive 0.4520 shares of Community West Bancshares common stock for each share they own, valuing United Security Bancshares at $10.88 per share based on Community West Bancshares' closing price of $24.06 on December 16, 2025 [2] - Insiders of United Security Bancshares will receive substantial benefits as part of change of control arrangements [2] Investigation Focus - The transaction agreement imposes significant penalties for United Security Bancshares if it accepts competing bids, which may limit shareholder options [3] - The investigation will assess whether the board of directors of United Security Bancshares is fulfilling its fiduciary duties to all shareholders [3]
Shareholder Alert: The Ademi Firm continues to investigate whether Mersana Therapeutics Inc. is obtaining a Fair Price for its Public Shareholders
Prnewswire· 2025-12-16 16:31
Core Viewpoint - Mersana is under investigation for potential breaches of fiduciary duty related to its transaction with Day One Biopharmaceuticals, which may not be in the best interest of all shareholders [1][3]. Transaction Details - Mersana shareholders will receive $25.00 per share in cash upfront, with potential contingent value rights payments of up to $30.25 per share, leading to a total equity value of approximately $129 million at closing and a total deal value of up to approximately $285 million if all milestone payments are achieved [2]. - The contingent payments are linked to clinical development, regulatory, and commercial milestones for Mersana's B7-H4-directed antibody-drug conjugate Emi-Le [2]. Board Conduct - The transaction agreement imposes significant penalties on Mersana for accepting competing bids, raising concerns about the board's fulfillment of fiduciary duties to shareholders [3].